Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Gross Margin (2021 - 2025)

HeartSciences' Gross Margin history spans 5 years, with the latest figure at 58.33% for Q4 2025.

  • For Q4 2025, Gross Margin changed N/A year-over-year to 58.33%; the TTM value through Jan 2026 reached 57.92%, up 6685.0%, while the annual FY2025 figure was 56.78%, 1052.0% down from the prior year.
  • Gross Margin reached 58.33% in Q4 2025 per HSCS's latest filing, down from 60.0% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 69.15% in Q2 2022 to a low of 23.09% in Q3 2021.
  • Average Gross Margin over 5 years is 56.36%, with a median of 60.51% recorded in 2025.
  • Peak YoY movement for Gross Margin: skyrocketed 1329bps in 2022, then crashed -781bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 23.09% in 2021, then soared by 58bps to 36.38% in 2022, then surged by 68bps to 61.03% in 2023, then grew by 13bps to 68.97% in 2024, then decreased by -15bps to 58.33% in 2025.
  • Per Business Quant, the three most recent readings for HSCS's Gross Margin are 58.33% (Q4 2025), 60.0% (Q3 2025), and 56.78% (Q2 2025).